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Summary 
Amyloid beta (Aβ) oligomers accumulate in brain tissue of Alzheimer disease patients 
and are related to pathogenesis. The precise mechanisms by which Aβ oligomers cause 
neurotoxicity remain unresolved. In this study, we investigated the role of ionotropic 
glutamate receptors on the intracellular Ca2+ overload caused by Aβ. Using rat cortical 
neurons in culture and entorhinal-hippocampal organotypic slices, we found that Aβ 
oligomers significantly induced inward currents, intracellular Ca2+ increases and 
apoptotic cell death through a mechanism requiring NMDA and AMPA receptor 
activation. The massive entry of Ca2+ through NMDA and AMPA receptors induced by 
Aβ oligomers caused mitochondrial dysfunction as indicated by mitochondrial Ca2+ 
overload, oxidative stress and mitochondrial membrane depolarization. Importantly, 
chronic treatment with nanomolar concentration of Aβ oligomers also induced NMDA- 
and AMPA-receptor dependent-cell death in entorhinal cortex and hippocampal slice 
cultures. Together, these results indicate that overactivation of NMDA and AMPA 
receptor, mitochondrial Ca2+ overload and mitochondrial damage underlie the 
neurotoxicity induced by Aβ oligomers. Hence, drugs that modulate these events can 
prevent from Aβ damage to neurons in Alzheimer´s disease.  
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Introduction 
The molecular mechanisms responsible for the development of the idiopathic 
cases of Alzheimer disease (AD) are unknown. Growing evidence indicates that 
cerebral elevation and accumulation of Aβ peptide mediate many aspects of AD 
pathogenesis. It has been difficult to determine which of the forms of Aβ induces 
neuropathological changes that characterize the disease. Oligomers have been found in 
mouse models of AD (Billings et al., 2005; Oddo et al., 2006) and have been detected in 
CSF (Kuo et al., 1996; Kayed et al., 2003) and brain tissue (Gong et al., 2003; Kayed et 
al., 2003; Lacor et al., 2004) of AD patients, where the soluble Aβ species appear to 
correlate with disease progression (Lue et al., 1999; McLean et al., 1999; Naslund et al., 
2000).  Several mechanisms have been proposed to understand the Aβ-mediated 
neurodegeneration. AD has been related to a general dyshomeostasis of [Ca2+]i. This 
hypothesis is substantiated by reports on dysregulation of [Ca2+]i promoted by Aβ 
(LaFerla, 2002). Whether Aβ directly alters lipid bilayer by forming pores or acts 
through proteinaceous receptor, for example α7-nACh or NMDA receptor is a matter of 
intense debate (Wang et al., 2000, Arispe et al., 2007, De Felice et al., 2007). Growing 
evidences point to a major role for changes in [Ca2+]i and Aβ-induced neuronal cell 
damage. First, Aβ oligomers provoke neurotoxicity by mechanisms that involve a 
channel independent disruption of the integrity of both plasma and intracellular 
membranes with elevation in [Ca2+]i (Demuro et al., 2005). Later, it has been reported 
that dynamin-1 degradation is the result of calpain activation induced by the Ca2+ influx 
mediated by NMDA receptors in hippocampal neurons (Kelly and Ferreira, 2006). Most 
recently, some studies have shown that Aβ oligomers bind to or in close proximity to 
NMDA receptor, triggering neuronal damage through NMDA receptor dependent Ca2+ 
 5
flux or implicating excitatory receptor activity in oligomer formation and accumulation 
at synapses (De Felice et al., 2007; Deshpande et al., 2009). 
On the other hand, accumulated evidence indicates that physiological 
concentrations of Aβ peptides can regulate the release of glutamate by acting on 
glutamatergic terminals (Kabogo et al., 2008). Consistent with that idea, soluble Aβ 
perturbs synaptic plasticity by altering glutamate recycling at the synapse and 
promoting synapse depression (Li et al., 2009). Furthermore, previous results have 
indicated that Aβ toxicity is mediated by Ca2+-dependent glutamate excitotoxicity 
(Mattson et al., 1992).  
Because the link between the Ca2+ increase and Aβ toxicity is still controversial, 
we examined the contribution of various routes of Ca2+ entry to Ca2+ overload in Aβ-
produced neurotoxicity. We found that Aβ oligomers generate glutamate-independent 
inward currents, dysregulate Ca2+ homeostasis and induce cell death through both 
NMDA and AMPA receptors in cultured neurons or in enthorinal cortex-hippocampus 
organotypic slices. In this apoptotic neuronal death caspase-dependent and independent 
pathways are involved. Aβ-induced changes of [Ca2+]i provoke mitochondrial Ca2+ 
overload, mitochondrial membrane depolarization and ROS generation. Antagonists of 
NMDA and AMPA receptor reduce deleterious events in mitochondria, indicating that 
Glu receptors initiate the Aβ-induced Ca2+ dysregulation in neurons.  
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Materials and Methods 
Drugs and culture medium. Neurobasal medium, B27 supplement, foetal bovine serum, 
horse serum and other culture reagents were from Gibco (Invitrogen, Barcelona, Spain). 
Receptor antagonists MK801, DAP5 (AP5), and memantine were all obtained from 
Tocris (Cookson, Bristol, UK). CNQX and other chemicals were from Sigma (St Louis, 
MO, USA). The general caspase inhibitor ZVAD and the caspase-3 specific inhibitor 
DEVD were purchased in Peptides International (Louisville, KY, USA). DPQ, the 
PARP-1 inbibitor, was obtained from Calbiochem (La Jolla, CA, USA). 
Preparation of Aβ oligomers. Aβ1-42 oligomers were prepared as reported previously 
(Klein, 2002).  Briefly, Aβ1-42 (ABX, Radeberg, Germany) was initially dissolved to 1 
mM in hexafluoroisopropanol (Sigma; St Louis, MO, USA) and separated into aliquots 
in sterile microcentrifuge tubes. Hexafluoroisopropanol was totally removed under 
vacuum in a speed vac system and the peptide film was stored dessicated at -80 ºC. For 
the aggregation protocol, the peptide was first resuspended in dry DMSO (Sigma; St 
Louis, MO, USA) to a concentration of 5 mM and Hams F-12 (PromoCell, Labclinics, 
Barcelona, Spain) was added to bring the peptide to a final concentration of 100 μM and 
incubated at 4 ºC for 24h. The preparation was then centrifuged at 14,000 x g for 10 min 
at 4 ºC to remove insoluble aggregates and the supernatants containing soluble Aβ1-42 
was transferred to clean tubes and stored at 4 ºC.  
Cortical cell culture. Primary neuron cultures were obtained from the cortical lobes of 
E18 Sprague-Dawley rat embryos according to previously described procedures 
(Gottlieb et al., 2006). Cells were resuspended in B27 Neurobasal medium plus 10% 
FBS (Sigma; St Louis, MO, USA) and then seeded onto poly-l-ornithine-coated glass 
coverslips at 1 x 105 cells per coverslip (12 mm in diameter) and 48-well plates at 1.5 x 
105  per well. One day later, the medium was replaced by serum-free-, B27-
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supplemented Neurobasal medium. The cultures were essentially free of astrocytes and 
microglia; they were maintained at 37 ºC and 5% CO2. Cultures were used 8-10 days 
after plating. 
Preparation of organotypic cultures. Brain was removed and two hemispheres were 
separated in HBSS. Talamus and midbrain was removed and each hemisphere sliced 
with a tissue chopper (McIlwan Tissue Chopper, Campden Instruments Ltd, Lafayette, 
IN, USA) in order to obtain coronal slices of 400 μm of thickness. Enthorinal cortex, in 
connection with hippocampus, were isolated under a dissection microscope, 2 slices 
plated on each Millicell CM culture inserts (Millipore Ibérica, Madrid, Spain) and 
maintained in Neurobasal medium supplemented with 0.5% B27, 25% horse serum, 
25% HBSS and 25 mg/ml gentamycin at 37°C. Experiments were performed at 7-10 
days in vitro. Cultures were immunostained with antibodies to neurofilament-L (NFL 
1:200; Cell Signaling Technology, Boston; MA) and choline acetyltransferase (ChAT 
40 μg/ml; Chemicon, Millipore Ibérica, Spain) and labeling was revealed with 
fluorescent goat anti-rabbit and donkey anti-goat secondary antibodies respectively 
(Alexa Fluor 488, Invitrogen, Barcelona, Spain) 
Electrophysiology. Whole-cell recordings were performed at room temperature using 
the EPC-7 patch-clamp amplifier (HEKA Elektronik, Lambrecht, Germany). Currents 
were recorded at a holding membrane potential of -70 mV. Extracellular bath solution 
with a pH of 7.3 contained the following (in mM): 140 NaCl, 5 KCl, 2.5 CaCl2, 1 
MgCl2, 10 HEPES and 10 mM glucose. Patch-clamp pipettes (3-5 MΩ) were filled with 
internal solution at a pH of 7.3 containing the following (in mM): 140 K-gluconate, 1 
CaCl2, 2 MgCl2, 10 HEPES, 10 EGTA, 2 Mg-ATP, 0.2 Na-GTP. 
Ca2+ imaging in the cytosol. [Ca2+]i was determined according to the method described 
previously (Grynkiewicz et al., 1985). Neurons were loaded with fura-2 AM (5 μM; 
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Invitrogen, Barcelona, Spain) in culture medium for 30 min at 37ºC. Cells were washed 
in HBSS containing 20 mM HEPES, pH 7.4, 10 mM glucose, and 2 mM CaCl2 
(incubation buffer) for 10 min at room temperature. Experiments were performed a 
coverslip chamber continuously perfused with incubation buffer at 4 ml/min. The 
perfusion chamber was mounted on the stage of a inverted epifluorescence microscope 
(Zeiss Axiovert 35; Oberkochen, Germany) equipped with a 150 W xenon lamp 
Polychrome IV (T.I.L.L. Photonics, Martinsried, Germany) and a Plan Neofluar 40 x oil 
immersion objective (Zeiss). Cells were visualized with a high-resolution digital 
black/white CCD camera (ORCA C4742-80-12 AG; Hamamatsu Photonics Iberica). 
[Ca2+]i was estimated by the 340/380 ratio method, using a Kd value of 224 nM. At the 
end of the assay, in situ calibration was performed with the successive addition of 10 
mM ionomycin and 2 M Tris/50 mM EGTA, pH 8.5. Data were analyzed with Excel 
(Microsoft, Seattle, WA, USA) and Prism (GraphPad Software, San Diego, CA, USA) 
software.      
Measurement of mitochondrial Ca2+. Rhod-2 AM was used to measure mitochondrial 
Ca2+ according to the previous procedure with modifications (Hajnóczky et al. 1995). 
Rhod2-AM has a net positive charge, which facilitates its sequestration into 
mitochondria due to membrane potential-driven uptake. Cell were loaded with 2 μM  
rhod2-AM for 6 hours. The residual cytosolic fraction of the dye was eliminated when 
the cells were kept in culture for an additional 18h after loading, whereas the 
mitochondrial dye fluorescence was maintained. Fluorescence images of rhod-2 were 
acquired using 550 nm excitation and 590 nm emission. The fluorescence of rhod-2 was 
not calibrated in terms of [Ca2+]mit since it is not a ratiometric dye. 
Measurement of Ca2+ in organotypic slices. Ca2+ levels in hippocampus were monitored 
by fluorescence microscopy using the Ca2+ indicator fluo-4 (Molecular Probes, Eugene, 
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OR). Slices were incubated with fuo-4-AM (5 μM and 0.01 % of pluronic acid) for 45 
min at 37 ºC. Experiments were performed in a chamber continuously perfused with 
incubation buffer. Drugs were perfused by a micromanifold with a quartz/polymide tube 
of 200 μm ID, attached to a micromanipulator in order to perfuse the drugs directly to 
the cells. The perfusion chamber was mounted on the stage of a Leica DMLFSA up-
right microscope equipped with a 150 W xenon lamp Polychrome V (T.I.L.L. 
Photonics, Martinsried, Germany) and a HCX Apo 40 x water immersion objective 
(Leica). Cells were visualized with a CCD camera (EM CCD 9100; Hamamatsu 
Photonics Iberica, Barcelona, Spain). 
Cell viability and toxicity assays. Cortical neurons at 8-10 days in culture were exposed 
for 24 hours to Aβ oligomers. Antagonists and inhibitors were added to the cultures 30 
min before the Aβ. Twenty four hours after drug application, cellular damage was 
estimated by measuring the level of lactate dehydrogenase released (LDH; Cytotox 96®, 
Promega, Madison, WI) from damaged cells into the culture media. Data were 
normalized to the activity of LDH released from vehicle-treated cells (100%) and 
calculated as a percentage of the control. Results were expressed as the means ± SEM of 
at least three independent experiments performed in triplicates.  
Hippocampus-entorhinal cultures were exposed to Aβ oligomers at 100 nM for 4 days. 
Antagonists were added to cultures 30 min before the Aβ. Cell death in organotypic 
cultures was evaluated by cellular uptake of propidium iodide (PI). Slices were stained 
by adding 10 μM PI into the culture for 2 h at 37° C and washed with PBS by two times 
for 10 min. Slices were fixed with 4% PFA in PBS for 40 min at room temperature 
(Pozzo-Miller et al., 1994). Afterwards, the slices were excited with 510–560 nm light 
and the emitted fluorescence acquired at 610 nm using a rhodamine filter on an inverted 
fluorescence microscope (Cell Observer Z1, Zeiss). PI fluorescence images were 
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captured with a Plan NeoFluar 2.5 x objective (Zeiss), using an EM CCD camera 
(Hamamatsu, C9100-13), controlled by Axio Vision program (Zeiss). Images were 
analyzed with the ImageJ analysis program (NIH, MD, USA) and neuronal cell death 
was expressed as the percentage of the mean gray value of each treatment vs. control.  
Measurement of intracellular reactive oxygen species. Neurons were exposed to Aβ 
oligomer alone or with GluR antagonists as described. Cells were loaded with CM-
H2DCFDA at 30 μM to assay the ROS levels. Calcein-AM (1 μM; Molecular Probes, 
Invitrogen, Barcelona, Spain) was used to quantify the number of cells within the 
reading field. Fluorescence was measured using a Synergy-HT fluorimeter (Bio-Tek 
Instruments Incl, Beverly, MA, USA) and excitation and emission wavelengths for CM-
H2DCFDA and calcein were as suggested by the supplier. All experiments (n≥3) were 
performed at least in quadruplicate and plotted as means ± SEM. 
Analysis of mitochondrial membrane potential. Neurons were exposed to Aβ oligomers 
alone or in presence of different drugs and the changes in mitochondrial membrane 
potential were monitored by reduction of JC-1 (Molecular Probes, Invitrogen, 
Barcelona, Spain), according to the manufacturer protocol. Briefly, after drug treatment, 
cells were loaded with 3 μM JC-1 for 15 min at 37 ºC and were washed with HBSS 
without phenol red by two times to eliminate the excess of dye. In the cytosol the 
monomeric form of this dye fluoresces green (excitation at 485 nm, emission at 527 
nm), whereas within the mitochondrial matrix highly concentrated JC-1 forms 
aggregates that fluoresce red (excitation at 485 nm, emission at 590 nm). Both JC-1 
monomers and aggregates were detectable using a Synergy-HT fluorimeter (Biotek 
Instruments) and the changes in mitochondrial potential were calculated as the red/green 
ratio in each condition. All experiments (n ≥ 3) were performed at least in triplicate and 
plotted as mean ± SEM. 
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Statistical Analysis. Data are presented as means ± SEM. Statistical analysis was carried 
out with the Student t test and, in all instances, a value of p < 0.05 was considered 
significant. 
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Results 
Aβ oligomers activate NMDA and AMPA receptors in neurons 
Dysregulation of intracellular Ca2+ homeostasis may underlie Aβ peptide 
toxicity in AD but the mechanisms are unknown. Here, we tested whether the activation 
of ionotropic GluRs is involved in neuronal response to Aβ 1-42 oligomeric peptide. 
Previous studies have shown that Aβ oligomers produce reversible synapse loss 
(Shankar et al., 2007), neuronal oxidative stress (De Felice at al., 2007) and dynamin-1 
degradation (Kelly and Ferreira, 2006) through an NMDA receptor dependent 
mechanism. First, using electrophysiological recording and Ca2+ imaging methods, we 
studied whether soluble Aβ oligomers interact with NMDA receptor in neurons. Whole-
cell patch-clamp recording was used to examine the effects of Aβ oligomers on cortical 
neurons in culture. In conditions which favour NMDA receptor activation (glycine 100 
µM and no Mg2+), Aβ oligomers (1 μM) induced an inward current in the majority of 
neurons examined (816 ± 101 pA; n=30). AP5 (100 μM), a competitive NMDA 
antagonist, reduced the peak of the currents (n=7). Silencing neural activity with TTX 
(1 μM) or using a calcium-free extracellular bath solution did not attenuate the response 
to Aβ oligomers suggesting a direct interaction of the peptide with NMDA receptors 
(n= 11 and 13 respectively; Fig 1A).  
To characterize further the properties of Aβ responses, we next monitored the 
concentration of intracellular Ca2+ [Ca2+]i in cultured cortical neurons. We found that 
oligomeric Aβ (5 μM) caused a robust and sustained increase in [Ca2+]i (270 nM, n=42), 
which is nearly abolished by NMDA receptor antagonists AP5, MK801 and memantine 
(n=70). Similarly, Aβ applied in Ca2+-free extracellular buffer containing EGTA 50 μM 
greatly reduced [Ca2+]i rise (n=11). In contrast, the AMPA/kainate antagonist CNQX 
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and the voltage-gated Ca2+ channel inhibitors nifedipine and verapamil were ineffective 
(n=66; Fig 1B).     
Together these results provide evidence indicating that Aβ oligomers activate 
NMDA receptors in cortical cultured neurons.  
Previous results have shown that Aβ(1-42) but not Aβ(1-40) closely interacts 
with synaptic AMPA receptors (Parameshwaran et al., 2007). Because of that, we next 
examined whether Aβ oligomers also activate AMPA receptors in cultured neurons. In 
the presence of Mg2+ and no glycine, Aβ (1 μM) alone elicited a small current (43 ± 14 
pA, n= 6) and co-applied with cyclothiazide (CTZ), an inhibitor of AMPA receptor 
desensitization, activated a sustained current (n=18; Fig 2A) that was blocked by the 
AMPA/kainate antagonist CNQX (n= 6; Fig 2A).  We then measured the effects of 
antagonists of NMDA or AMPA receptor on [Ca2+]i in neurons exposed to Aβ plus CTZ 
(5 μM and 100 μM, respectively; Fig 2B). In these experimental conditions, Aβ 
oligomers increased the [Ca2+]i in 308 ± 44.7 nM (100 % of Ca2+ increase, control 
value, n=23) a level that was substantially reduced by CNQX 30 μM (50 ± 4 % of 
control, n=17) and by AP5 100 μM (45 ± 2 % of control, n=17; Fig. 2B). Co-incubation 
with CNQX and AP5 further reduced [Ca2+]i to 14 ± 2 % of control (n=18; Fig. 2B), 
Any facilitatory role of AMPA receptors on Aβ-induced NMDA receptor response was 
excluded since in physiological conditions (2 mM Mg2+, 0.1 mM Gly) CNQX did not 
modify the Aβ-produced inward current (98.3 ± 6.8 % Aβ + CNQX vs 100 % Aβ alone, 
n=6). These results indicate that Aβ oligomers in presence of CTZ activate AMPA 
receptors and that the contribution of both receptors to Ca2+ influx is substantial.  
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Aβ oligomers trigger apoptotic neuronal death through NMDA and AMPA 
receptors 
As illustrated above, NMDA and AMPA receptor activation by Aβ oligomers in 
neurons causes an increase in basal [Ca2+]i levels. Because GluRs mediate Ca2+-
dependent–neuronal cell death, we tested whether activation of these receptors by Aβ is 
toxic to neurons. Incubation of Aβ oligomers for 24h caused neuronal death in a dose-
dependent manner (Fig 3A). In turn, Aβ toxicity (5 μM; 15.2 ±1.8 % cell death vs. non-
treated cells) was greatly attenuated by NMDA receptor antagonists AP5 100 μM, 
MK801 50 μM and memantine 50 μM and by AMPA/kainate receptor antagonist 
CNQX 30 μM (Fig. 3B). 
Previous reports have shown that oligomeric Aβ peptides induce mitochondrial 
dependent-apoptotic cell death in cultured neurons (Sanz-Blasco et al., 2008). Damage 
to mitochondria can result in both caspase-dependent and -independent cell death. To 
characterize whether these two types of apoptosis are involved in GluR-mediated Aβ 
toxicity, we used the pan-caspase inhibitor ZVAD-F, a caspase-3 inhibitor Ac-DEVD-F 
and the nuclear enzyme poly (ADP-ribose) polymerase-1 (PARP-1) inhibitor DPQ. We 
observed that ZVAD-F (50 μM), DEVD (100 μM) and DPQ (30 μM) reduced Aβ-
induced cell death (Fig. 3C). Aβ toxicity decreased further by blocking simultaneously 
caspase-3 and PARP-1 with DEVD + DPQ (Fig. 3C). These results indicate that Aβ 
oligomers induce caspase-3- and PARP-1-dependent neuronal death via activation of 
NMDA and AMPA receptors.  
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Aβ oligomers induce mitochondrial damage by activating glutamate receptors 
To characterize further the signalling cascades triggered by Aβ oligomers, we 
next studied mitochondrial Ca2+ uptake in neurons with rhod-2 AM, a cationic indicator 
which loads selectively into respiring mitochondria. To assess that feature, we used 
FCCP 25 μM, a protonophore that collapses the mitochondria membrane potential and 
releases Ca2+ from mitochondria. As expected, FCCP induced a rapid and transitory 
reduction of rhod-2 fluorescence (Fig 4A). In these loading conditions, we assayed the 
effects of Aβ oligomers on [Ca2+]mit. Aβ 5 μM increased [Ca2+]mit levels with respect to 
the control assay (incubation buffer). Ca2+ rise was reduced by NMDA antagonist 
MK801, AP5 and memantine, whereas CNQX was ineffective (Fig 4B and C). These 
results indicate that Aβ induces mitochondrial Ca2+ overload and that this effect can be 
prevented by NMDA receptors antagonists. 
Aβ induces mitochondrial dysfunction by an NMDA receptor-dependent 
mechanism in hippocampal neurons (De Felice et al., 2007). Consistently, we observed 
that NMDA antagonists reduce Aβ-generated oxidative stress (Fig. 4D) and 
mitochondrial depolarization (Fig. 4E) in cortical neurons. Incubation of neurons with 
Aβ (5 µM; 2 hours) increased ROS levels to 124 ± 7.8 % and reduced the mitochondrial 
potential to 75 ± 3% with respect to control (100%, non-treated cells). Both parameters 
were partially restored by NMDA receptor antagonists AP5 (102 ± 11 % and 90 ± 2 %, 
respectively) and MK801 (104 ± 3.4 % and 85 ± 3 %, respectively) and by AMPA 
receptor antagonist CNQX (106 ± 6.3 % and 86 ± 3 %, respectively; Fig. 4D and E).  
Taken together, these results demonstrate that both NMDA and AMPA receptors 
mediate Aβ-induced mitochondrial dysfunction. 
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Blockade of NMDA and AMPA receptors protect from Aβ-induced toxicity in 
entorhinal cortex-hippocampus organotypic slices 
We next examined if Aβ oligomers induce Ca2+ and cell death in a more integral 
preparation. To that end, we used organotypic cultures from entorhinal cortex and 
hippocampus, two regions that are profoundly affected early in Alzheimer´s disease and 
cause cardinal symptoms of short-term memory loss (De Lacoste and White, 1993).   
Slices for organotypic cultures were prepared as to preserve major connections 
between entorhinal cortex and hippocampus (Kluge et al., 1998). Thus, neurofilament 
immunofluorescence with antibodies to NFL revealed axons entering the hippocampus 
from the entorhinal cortex and layer preservation of these structures (Fig. 5A, B and C). 
In addition, antibodies to choline acetyltransferase show cholinergic fibers and 
terminals in entorhinal cortex (Fig. 5 D).  
To monitor the effects of Aβ in these cultures, we measured Ca2+ levels after 
application of Aβ to neurons from CA1 in organotypic slices. We found that oligomeric 
Aβ (20 μM) increased [Ca2+]i in those cells, and that this response was greatly reduced 
by MK801 (50 μM, n=9) and CNQX (30 µM, n=43) treatment (Fig 5E). Aβ-induced 
[Ca2+]i decreased further by blocking simultaneously NMDA and AMPA receptors with 
MK801+CNQX (n=50; Fig 5E). In turn, Ca2+ responses elicited by kainate (1 mM) 
served as a positive control to evaluate the integrity of the culture (Fig. 5E). 
Finally, to test Aβ toxicity we chronically incubated cultures with low 
concentrations of Aβ oligomers (100 nM) for 4 days, and used PI fluorescence to 
measure cell death. PI uptake in slices exposed to Aβ showed 4.1 ± 1.0 and 3.8 ± 0.9 
fold over the control slices (n=7) in hippocampus and entorhinal cortex respectively 
(Fig. 5F-G).  Instead, co-incubation of GluR antagonists MK801 (10 μM) or CNQX (30 
μM) with Aβ oligomers reduced PI uptake to 0.9 ± 0.2 and 1.3 ± 0.4 fold in 
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hippocampus and to 1.2 ± 0.4 and 0.73 ± .01 fold in entorhinal cortex as compared to 
control slices treated with MK801 or CNQX alone (Fig 5F-G). 
Overall, these results indicate that Aβ induces cytosolic Ca2+ overload and cell 
death in organotypic cultures, and that antagonists of NMDA and AMPA receptors 
prevent both effects. 
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Discussion 
The results reported here show that Aβ oligomers dysregulate intracellular Ca2+ 
homeostasis through activation of both NMDA and AMPA receptors in neurons in vitro 
and in enthorinal cortex-hippocampus organotypic cultures. Ca2+ influx by GluRs 
produces mitochondrial dysfunction as indicated by mitochondrial Ca2+ overload, 
oxidative stress and mitochondrial membrane depolarization, which ultimately leads to 
apoptotic cell death. In turn, NMDA and AMPA receptor antagonists protect neurons 
against Aβ-mediated toxicity by attenuating Ca2+ influx and associated signaling 
cascades. 
Several mechanisms may account for the Ca2+ mobilizing actions of Aβ 
oligomers in the experimental paradigm used in the current study. These include a direct 
interaction with membrane structure; insertion into the membrane to form a cation-
conducting pore; activation of cell surface receptors coupled to Ca2+ influx; and 
oxidative stress leading to dysregulation of mitochondrial homeostasis (Wang et al., 
2000, Arispe et al., 2007, De Felice et al., 2007, Sanz-Blasco et al., 2008). Our data 
show that increases in [Ca2+]i induced by Aβ are mainly due to Ca2+ entry through the 
plasma membrane rather than release from intracellular Ca2+ stores as they were entirely 
prevented by removal of extracellular Ca2+. In addition, we provide evidence that 
activation of NMDA and AMPA receptors by oligomeric Aβ is the primary and most 
important component related to Ca2+ dysregulation, mitochondrial alteration and cell 
death in neurons. Thus, Aβ oligomers applied alone or in conjunction with 
cyclothiazide, trigger inward currents that are abolished by NMDA or AMPA receptor 
antagonists, respectively. The amplitude of those currents is not affected by TTX or by 
removal of extracellular Ca2+ from bath solution, indicating that endogenous glutamate 
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release by Aβ oligomers does not contribute to receptor activation. Ca2+ imaging results 
confirmed that Aβ oligomers activate NMDA and AMPA receptors since the induced 
increase in [Ca2+]i is greatly reduced by MK801, AP5 and memantine, and also by 
CNQX.  
Consistent with the findings reported here, it has been suggested that Aβ 
interacts directly with NMDA and AMPA receptors and modulates channel properties. 
Thus, treatment of Aβ oligomers potentiate NMDA-evoked firing and induce a rapid 
and transient increase in intracellular Ca2+ levels that is blocked by memantine in 
mature hippocampal neurons (Szegedi et al., 2005; De Felice et al., 2007). In turn, Aβ 
oligomers have also been shown to induce Ca2+ influx, calpain activation and dynamin-
1 degradation mediated by NMDA receptor activation (Kelly and Ferreira, 2006). In 
contrast, the reported effects of Aβ on AMPA receptors are apparently contradictory 
depending on the aggregation state of the peptide itself or the cell type studied. Thus, 
the fibrillar form of Aβ can robustly activate Ca2+ permeable AMPA receptor in 
neuronal cell lines (Blanchard et al., 2004) while it attenuates AMPA-evoked neuronal 
firing in CA1 neurons (Szegedi et al., 2005) and currents mediated by recombinant 
AMPA receptors expressed in Xenopus oocytes (Tozaki et al., 2002). The present study, 
however, indicates unambiguously that Aβ oligomers activate both NMDA and AMPA 
receptors which leads to Ca2+ dysregulation. 
Our findings show that massive entry of Ca2+ into the cytosol induced by Aβ 
oligomers caused mitochondrial Ca2+ overload. This effect was absent in cells incubated 
previously with NMDA receptor antagonists indicating that Aβ oligomers promote a 
large and sustained entry of Ca2+ through NMDA receptors which is sufficient to 
activate the mitochondrial Ca2+ uniporter. Mitochondrial Ca2+ overload during 
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excitotoxicity favors ROS production and mitochondrial membrane depolarization 
(revised in Atlante et al., 2001). Consistent with that, we also observed these two 
deleterious features after treatment with Aβ oligomers, and that both are prevented by 
NMDA and AMPA receptor antagonists.    
Increased levels of free radicals and Ca2+ overload in mitochondria lead to the 
release into the cytoplasm of proapoptotic factors (Nicholls and Budd, 2000). 
Cytochrome c and the apoptosis-inducing factor are released from mitochondria to the 
cytosol and the nucleus, in which they induce activation of caspase-3 and PARP-1. In 
the current study, the fact that caspase-3 and PARP1 inhibition rescue neurons from 
Aβ oligomeric toxicity strongly suggests that Aβ kills neurons by apoptosis involving 
both caspase-dependent and independent pathways. 
Finally, we observed that Aβ oligomers induce neurotoxicity in cortical cell 
culture, and in entorhinal cortex and hippocampal organotypic slices. That toxicity was 
attenuated by NMDA and AMPA receptor antagonists in the two preparations assayed. 
Of all vulnerable regions, pyramidal neurons of the neocortex, entorhinal cortex and 
hippocampus are affected early in the disease process (Butterfield and Pocernich, 2003; 
Cacabelos et al.1999, Francis, 2003).  It also has been proposed that a sustained increase 
in extracellular glutamate levels and activation of the NMDA receptor is associated with 
the cognitive deficits and loss of neurons observed in AD brains (Mattson and Chan, 
2003; Hynd et al., 2004). Our current results indicate that excessive NMDA and AMPA 
receptor activity in AD may be a consequence of Aβ interaction with those receptors in 
crucial neuronal circuitries early in the disease.  
In summary, our data point to dysregulation of intracellular Ca2+ homeostasis 
underlies Aβ bloomer toxicity. Aβ peptides bind to NMDA and AMPA receptors 
disturbing the cytosolic and mitochondrial Ca2+ levels. Mitochondrial Ca2+ overload 
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triggers mitochondrial dysregulation that induces apoptosis by caspase-dependent and 
independent pathways.  Drugs that modulate these events can prevent from Aβ damage 
to neurons in Alzheimer´s disease. 
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Legends 
Figure 1. Aβ oligomers activate NMDA receptors and induce Ca2+ influx into 
neurons. A, Aβ (1 μM) evokes inward, non-desensitizing currents when applied 
together with glycine in Mg2+-free medium. Aβ-activated currents are blocked by AP5 
(100 μM), a selective NMDA receptor antagonist. TTX (1 μM) and calcium-free 
extracellular bath solution do not attenuate Aβ-induced inward currents. B, Aβ (5 μM) 
induces a rapid increase in [Ca2+]i, an effect that is blocked by NMDA receptor 
antagonists, MK801, AP5 and memantine, or by removal of Ca2+from the perfusate. 
Voltage-gated Ca2+ channel inhibitors nifedipine and verapamil and CNQX do not 
diminish Aβ response. 
  
Figure 2. Aβ oligomers activate AMPA receptors and increase [Ca2+]i in neurons. 
A, Aβ (1 μM) together with CTZ (100 μM) evokes inward, non-desensitizing currents 
in the presence of Mg2+. Currents are blocked by the AMPA/kainate receptor antagonist 
CNQX (30 μM). B, Aβ in conjunction with CTZ induces [Ca2+]i increase, that is 
partially blocked by CNQX and AP5, and further reduced by both antagonists applied 
together. 
 
Figure 3. Aβ oligomers trigger neuronal apoptotic death by activating NMDA and 
AMPA/kainate receptors. A, Dose-response toxicity of Aβ oligomers in cortical 
neurons in culture as measured 24 h later with the LDH viability assay. B, Toxicity is 
prevented by co-application of Aβ oligomers (5 μM) with NMDA receptor antagonists 
AP5 (100 μM), MK801 (50 μM) and memantine (50 μM), and with AMPA/kainate 
receptor antagonist CNQX (30 μM). C, Aβ induced-toxicity was reduced by the broad-
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spectrum caspase-inhibitor ZVAD (50 μM), by caspase-3 inhibitor DEVD (100 μM) 
and by PARP-1 inhibitor DPQ (30 μM). (* p< 0.05, ** p < 0.01 for each comparison 
between Aβ alone and the co-applied with GluR antagonist or the corresponding 
inhibitor). 
 
Figure 4. Blockade of glutamate receptors attenuates Aβ-induced mitochondrial 
alterations. Neurons, loaded with Rhod-2 AM, were exposed to A FCCP (25 μM) used 
as an internal control to release Ca2+ from mitochondria, or to B Aβ alone (5 μM) or 
together with NMDA and AMPA receptor antagonists. B and C, [Ca2+]mit induced by 
Aβ is reduced by NMDA receptor antagonists. Recordings in B illustrate average ± 
SEM responses of 74 cells from at least 5 experiments, and histogram represents 
average ± SEM of area under Ca2+ curve for each condition. D and E, Cultures were 
first exposed to Aβ alone or in conjunction with GluR antagonists for 2 hours, and cells 
were immediately loaded with the corresponding dyes to monitor ROS generation and 
mitochondrial depolarization by fluorimetry. NMDA and AMPA/kainate receptor 
antagonists prevent the increase in radical oxygen species and mitochondrial 
depolarization produced by Aβ. * p < 0.05,  ** p < 0.01 for each antagonist versus Aβ. 
 
Figure 5. MK801 and CNQX reduce Aβ-induced [Ca2+]i rises and abolish cell 
death in entorhinal cortex-hippocampus organotypic cultures. Cultures were fixed 
at 7 DIV and characterized by immunofluorescence with antibodies to neurofilaments 
(NFL) and cholinergic terminals (ChAT). A, B, Hippocampus and entorhinal cortex 
showed profuse staining with NFL antibody. C, Square shows the magnification in A of 
neuronal fibers from entorhinal cortex entering in CA1. D, Cholinergic fibers revealed 
with ChAT in the entorhinal cortex (ECx) at high magnification. E, Aβ (20 μM) 
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induces a rapid increase in [Ca2+]i in hippocampus, an effect that is blocked by NMDA 
receptor antagonists MK801 (50 μM; n=9) and by AMPA receptor antagonist CNQX 
(30 µM; n=43) and further reduced by both antagonists applied together (n=50). Kainate 
(Kai) 1 mM also increases [Ca2+]i  in the same selected neurons. F, G Histogram and 
representative fields showing Aβ (100 nM, 4 days) toxicity in cultures treated after 7 
DIV and protection when oligomers are applied in conjunction with MK801 (10 μM) or 
CNQX (30 μM). Scale bar in G represent 500 μm. F, Bars (gray value/area) represent 
neuronal cell death occurs in Aβ-treated hippocampus and entorhinal cortex. MK801 
and CNQX mainly blocked the cell damage in both areas. Bars in F represent the 
average ± SEM from 5 experiments. # < 0.05 for comparison Aβ vs control treatments. * 
p < 0.05 for comparison of Aβ vs antagonist treatment . 
 





